{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:00:58Z","timestamp":1791820858870,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ctim.2024.103053","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:30:49Z","timestamp":1716618649000},"page":"103053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"83","author":[{"given":"Lili","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2024.103053_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctim.2024.103053_bib2","first-page":"84","article-title":"Doxorubicin, DNA torsion, and chromatin dynamics","volume":"1845","author":"Yang","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.ctim.2024.103053_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"issue":"25","key":"10.1016\/j.ctim.2024.103053_bib4","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ctim.2024.103053_bib5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ejca.2007.01.040","article-title":"Prevention of anthracycline-induced cardiotoxicity in children: the evidence","volume":"43","author":"van Dalen","year":"2007","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ctim.2024.103053_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"issue":"36","key":"10.1016\/j.ctim.2024.103053_bib7","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ctim.2024.103053_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ctim.2024.103053_bib9","first-page":"15","article-title":"Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: preventive strategies and treatment","volume":"11","author":"Cai","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ctim.2024.103053_bib10","article-title":"Understanding anthracycline cardiotoxicity from mitochondrial aspect","volume":"13","author":"Huang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.ctim.2024.103053_bib11","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.ijcard.2012.06.023","article-title":"Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study","volume":"167","author":"Kaya","year":"2013","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.ctim.2024.103053_bib12","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","article-title":"Protective effects of carvedilol against anthracycline-induced cardiomyopathy","volume":"48","author":"Kalay","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ctim.2024.103053_bib13","article-title":"Statin Induced Autoimmune Necrotizing Myopathy (SIANM): an alarming adverse event of a familiar medication","volume":"14","author":"Ganta","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ctim.2024.103053_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacbts.2021.11.010","article-title":"The quest for an early marker of anthracycline-induced cardiotoxicity","volume":"7","author":"Ibanez","year":"2022","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"10.1016\/j.ctim.2024.103053_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci Trends"},{"key":"10.1016\/j.ctim.2024.103053_bib16","doi-asserted-by":"crossref","first-page":"1047700","DOI":"10.3389\/fcvm.2022.1047700","article-title":"Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy","volume":"9","author":"Lv","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ctim.2024.103053_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111582","article-title":"Shenmai injection improves doxorubicin cardiotoxicity via miR-30a\/Beclin 1","volume":"139","author":"Zhang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ctim.2024.103053_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fphar.2020.00815","article-title":"Shenmai injection protects against doxorubicin-induced cardiotoxicity via maintaining mitochondrial homeostasis","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"issue":"04","key":"10.1016\/j.ctim.2024.103053_bib19","first-page":"355","article-title":"Observation on the efficacy of shenmai injection combined with chemotherapy in the treatment of middle and advanced malignant tumours","volume":"42","author":"Liu","year":"2023","journal-title":"Editor Board Acta Acad Med Wannan"},{"key":"10.1016\/j.ctim.2024.103053_bib20","unstructured":"Guidelines for Chinese medicine diagnosis and treatment of chronic heart failure (2022). J Tradit Chin Med; 64(07); 2023: p. 743\u20136."},{"key":"10.1016\/j.ctim.2024.103053_bib21","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ctim.2024.103053_bib22","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ctim.2024.103053_bib23","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ctim.2024.103053_bib24","first-page":"46","article-title":"Shenmai injection protects against myocardial damage caused by adriamycin in 102 cases","volume":"02","author":"An","year":"2001","journal-title":"Tradit Chin Med Res"},{"issue":"12","key":"10.1016\/j.ctim.2024.103053_bib25","first-page":"928","article-title":"Observations on the prevention of cardiotoxicity of anthracycline-based chemotherapeutic drugs by Shenmai injection","volume":"44","author":"Chen","year":"2009","journal-title":"Zhejiang J Tradit Chin Med"},{"issue":"04","key":"10.1016\/j.ctim.2024.103053_bib26","first-page":"267","article-title":"Protective effect of coenzyme Q10 in combination with shenmai injection on adriamycin cardiotoxicity","volume":"33","author":"Li","year":"2010","journal-title":"Editor Board Acta Acad Med Jining"},{"issue":"12","key":"10.1016\/j.ctim.2024.103053_bib27","first-page":"1661","article-title":"Protective effect of dexpropylenimine combined with shenmai injection on anthracycline-induced cardiotoxicity","volume":"23","author":"Lin","year":"2016","journal-title":"Clin Med Eng"},{"issue":"05","key":"10.1016\/j.ctim.2024.103053_bib28","first-page":"633","article-title":"The effect of dexpropylenimine and shenmai injection combination therapy on reducing cardiotoxicity in acute leukaemia chemotherapy","volume":"17","author":"lv","year":"2017","journal-title":"J Trop Med"},{"issue":"01","key":"10.1016\/j.ctim.2024.103053_bib29","first-page":"66","article-title":"Effect of shenmai injection on cardiac enzyme levels in malignant tumour patients receiving epirubicin chemotherapy","volume":"27","author":"Ma","year":"2014","journal-title":"J Basic Clin Oncol"},{"issue":"30","key":"10.1016\/j.ctim.2024.103053_bib30","first-page":"3327","article-title":"Protective effect of shenmai injection on myocardial damage caused by postoperative chemotherapy in breast cancer patients","volume":"25","author":"Pan","year":"2016","journal-title":"Mod J Integr Tradit Chin West Med"},{"issue":"08","key":"10.1016\/j.ctim.2024.103053_bib31","first-page":"47","article-title":"Clinical observation on the prevention and treatment of Zoerythromycin cardiotoxicity in patients with acute myeloid leukaemia by shenmai injection","volume":"46","author":"Sun","year":"2012","journal-title":"Shanghai J Tradit Chin Med"},{"issue":"05","key":"10.1016\/j.ctim.2024.103053_bib32","first-page":"47","article-title":"Clinical study of dexpropylenimine combined with shenmai to reduce anthracycline cardiotoxicity","volume":"26","author":"Wang","year":"2014","journal-title":"Med J Chin People\u2019s Health"},{"issue":"13","key":"10.1016\/j.ctim.2024.103053_bib33","first-page":"1169","article-title":"Study on the protective effect of Shenmai injection on adriamycin cardiotoxicity","volume":"27","author":"Wang","year":"2012","journal-title":"Clin Focus"},{"issue":"05","key":"10.1016\/j.ctim.2024.103053_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1142\/S0192415X17500094","article-title":"Evaluation of the efficacy of shenmai injection in improving cardiotoxic side effects of drugs","volume":"12","author":"Wang","year":"2017","journal-title":"China Pract Med"},{"key":"10.1016\/j.ctim.2024.103053_bib35","first-page":"263","article-title":"Electrocardiographic analysis of 83 cases of breast cancer treated with adriamycin-based chemotherapy","volume":"04","author":"Xiong","year":"2006","journal-title":"Proc Clin Med"},{"issue":"13","key":"10.1016\/j.ctim.2024.103053_bib36","first-page":"3078","article-title":"Prevention and treatment of acute cardiotoxicity of anthracyclines in elderly patients","volume":"11","author":"Xue","year":"2011","journal-title":"Chin J Misdiagnostics"},{"issue":"02","key":"10.1016\/j.ctim.2024.103053_bib37","first-page":"138","article-title":"Cardioprotective effect of shenmai injection on female breast cancer chemotherapy patients","volume":"27","author":"Yang","year":"2011","journal-title":"J Clin Cardiol"},{"issue":"32","key":"10.1016\/j.ctim.2024.103053_bib38","first-page":"4562","article-title":"Dexpropylenetramine in combination with Shenmai Injection. Cardiotoxicity of dexpropylenimine combined with shenmai injection in patients with anthracycline-induced breast cancer","volume":"26","author":"Yu","year":"2015","journal-title":"China Pharm"},{"issue":"02","key":"10.1016\/j.ctim.2024.103053_bib39","first-page":"214","article-title":"Effects of shenmai injection on myocardial function and immune function in breast cancer patients treated with postoperative chemotherapy","volume":"20","author":"Zhang","year":"2020","journal-title":"Eval Anal Drug-Use Hosp China"},{"issue":"7","key":"10.1016\/j.ctim.2024.103053_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41569-020-00503-2","article-title":"Artificial intelligence-enhanced electrocardiography in cardiovascular disease management","volume":"18","author":"Siontis","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ctim.2024.103053_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cca.2016.02.030","article-title":"The clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome","volume":"456","author":"Kim","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"Suppl 7","key":"10.1016\/j.ctim.2024.103053_bib42","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","article-title":"Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines","volume":"23","author":"Curigliano","year":"2012","journal-title":"Ann Oncol"},{"issue":"36","key":"10.1016\/j.ctim.2024.103053_bib43","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ctim.2024.103053_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1745-6215-11-32","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"11","author":"Schulz","year":"2010","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.ctim.2024.103053_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1756-5391.2010.01055.x","article-title":"Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica","volume":"3","author":"Bian","year":"2010","journal-title":"J Evid Based Med"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229924000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229924000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T09:49:38Z","timestamp":1718531378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229924000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":45,"alternative-id":["S0965229924000414"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2024.103053","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2024.103053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103053"}}